High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients

NCT03179761 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic Cell Transplantation

Interventions

BIOLOGICAL: Quadrivalent Inactivated Influenza Vaccine
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Trivalent Influenza Vaccine

Sponsor

Vanderbilt-Ingram Cancer Center